Ready for the "NEW YOU"?!?!
Piracetam has been investigated for the past six decades as a potential treatment for several conditions including stroke, seizures, dementia, and alcoholism.
Several studies suggest piracetam offers promise in the treatment of central nervous system disorders including Parkinson’s disease, epilepsy, and tardive dyskinesia.
Piracetam is 2-oxo-1 pyrrolidineacetamide; its shares the same 2-oxo-pyrrolidine base structure with 2-oxo-pyrrolidine carboxylic acid (pyroglutamate)
The effects of piracetam are similar to those of such as noopept. While the chemical structure is technically defined as a racetam, the structure is similar to racetams in that of a noopept-like.